Grafa News and Videos — Page 514

Taylor Devices (NASDAQ:TAYD) reported fiscal Q4 2026 sales of $8.95 million, down 42.5% from $15.56 million a year earlier, while net income fell to $1.87 million.

Sypris Solutions (NASDAQ:SYPR) reported Q2 2026 revenue of $30.3 million, down 3.5% year over year, while net loss widened to $3.1 million.

Eltek (NASDAQ:ELTK) reported Q2 2026 revenue of $11.5 million, down 8% year over year, while net loss reached $2.7 million.

Klarna Group (NYSE:KLAR) reported Q2 2026 revenue of $1.042 billion, up 27% year over year, as GMV increased 18% to $36.6 billion.

BlossomHill Therapeutics (NASDAQ:BLSM) received FDA Fast Track designation for BH-30643 in adults with advanced or metastatic EGFR C797S-positive non-small cell lung cancer.

Flotek Industries (NYSE:FTK) reaffirmed 2026 revenue guidance of $340–$350 million as work on its Puerto Rico power project was halted.

Immatics (NASDAQ:IMTX) reported Q2 2026 collaboration revenue of $10.4 million, up from $5.4 million, while its net loss narrowed to $71.2 million.

Amylyx Pharmaceuticals (NASDAQ:AMLX) said avexitide met the Phase 3 LUCIDITY primary endpoint with a 55% reduction in Level 2 and Level 3 hypoglycemic events versus placebo.

Canadian Solar (NASDAQ:CSIQ) said the remaining U.S. patent proceeding brought by Maxeon Solar was resolved in its favor after the federal infringement lawsuit was dismissed with prejudice.